Rhabdomyolysis induced by rosuvastatin combined with entecavir: a case report

被引：0
作者：
Wen Wang
Xu Lu
Chengbo Li
Wei Teng
Wei Cui
机构：
[1] The First Affiliated Hospital of China Medical University,Department of Infectious Diseases
来源：
BMC Infectious Diseases | / 22卷
关键词：
Rhabdomyolysis; Rosuvastatin; Entecavir;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 13 条
  • [1] Zutt R(2010)Recurrent rhabdomyolysis: screening for underlying disease Ned Tijdschr Geneeskd 154 A2290-385
  • [2] van der Kooi AJ(2005)Rhabdomyolysis: an evaluation of 475 hospitalized patients Medicine (Baltimore) 84 377-283
  • [3] Linthorst GE(2009)Rhabdomyolysis: a review of the literature Neth J Med 67 272-29K
  • [4] Wanders RJ(2003)Benefit–risk assessment of rosuvastatin 10 to 40 milligrams Am J Cardiol 92 23K-undefined
  • [5] Verschuuren JJ(2017)Statins, muscle disease and mitochondria J Clin Med 6 75-undefined
  • [6] de Visser M(undefined)undefined undefined undefined undefined-undefined
  • [7] Melli G(undefined)undefined undefined undefined undefined-undefined
  • [8] Chaudhry V(undefined)undefined undefined undefined undefined-undefined
  • [9] Cornblath DR(undefined)undefined undefined undefined undefined-undefined
  • [10] Khan FY(undefined)undefined undefined undefined undefined-undefined
12